French implant reimbursement cut proposals:
This article was originally published in Clinica
The French Healthcare Products Economics Committee, which fixes the reimbursement tariff of medical devices sold to the private sector, has announced that it intends to cut by 6% the tariff for mechanical suture and ligament implants. Manufacturers and distributors have until December 27 to either write to the committee or to ask for a meeting to discuss the issue.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.